View of Enhanced antitumor activity of DHMEQ, a NF-κB Inhibitor, on Cholangiocarcinoma Cell Lines by Decreasing the Expression of ABC Transporters

Return to Article Details Enhanced antitumor activity of DHMEQ, a NF-κB Inhibitor, on Cholangiocarcinoma Cell Lines by Decreasing the Expression of ABC Transporters Download Download PDF